太極實業(600667.SH):子公司中標10.9億元的大唐智華中國雲-邛崍IDC項目
格隆匯 9 月 14日丨太極實業(600667.SH)公佈,公司子公司信息產業電子第十一設計研究院科技工程股份有限公司(“十一科技”)於近日收到大唐智華(深圳)科技發展有限公司(招標人,項目業主)發來的《中標通知書》,確認十一科技為大唐智華(深圳)科技發展有限公司中國雲-邛崍IDC項目的EPC中標單位,中標金額約10.90億元。
中標範圍:項目新建辦公樓一棟、數據中心樓四棟及其配套設施,滿足8000台機櫃使用需求,總建築面積約為115559平方米,工作範圍包括數據中心和運維辦公樓的土建工程、機電工程、裝飾工程、室外硬化綠化等工程的設計和施工。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.